Mark Dybul

Overview

Mark Dybul received an average of $4M in total compensation, including $469K in salary, at Enochian Biosciences from 2019 to 2022.

Source: SEC filings on May 16, 2023, January 27, 2022, and February 3, 2021.

Related executives

We found four more executives who work or worked at Enochian Biosciences.

Luisa Puche

Enochian Biosciences

Chief Financial Officer

Eric Leire

Enochian Biosciences

Chief Executive Officer

Robert Wolfe

Enochian Biosciences

Chief Financial Officer

Lone Degn

Enochian Biosciences

Chief Financial Officer

News

You may also like